Manya Yu

No. 16369 Jingshi Road
Jinan, 250014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Properties of Heavy Cosmic Nuclei Phosphorus, Chlorine, Argon, Potassium, and Calcium: Results from the Alpha Magnetic Spectrometer.

Properties of Heavy Cosmic Nuclei Phosphorus, Chlorine, Argon, Potassium, and Calcium: Results from the Alpha Magnetic Spectrometer.

Journal: Physical review letters

Published: February 23, 2026

Case Report: Ablation as novel x therapy in the regimen for frail hematological malignancies with extramedullary lesion.

Case Report: Ablation as novel x therapy in the regimen for frail hematological malignancies with extramedullary lesion.

Journal: Frontiers in oncology

Published: October 12, 2025

Exploring the applicability, combined strategies, and challenges of ablation in hematology based on its characteristics and immunomodulatory mechanisms.

Exploring the applicability, combined strategies, and challenges of ablation in hematology based on its characteristics and immunomodulatory mechanisms.

Journal: Clinical and experimental medicine

Published: October 05, 2025

Guizhi Fuling decoction protects against bone destruction via suppressing exosomal ERK1 in multiple myeloma.

Guizhi Fuling decoction protects against bone destruction via suppressing exosomal ERK1 in multiple myeloma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 05, 2024

Guizhi Fuling capsules can alleviate bortezomib-induced peripheral neuropathy by decreasing Interleukin-6 levels to regulate mTOR pathway-induced autophagy.

Guizhi Fuling capsules can alleviate bortezomib-induced peripheral neuropathy by decreasing Interleukin-6 levels to regulate mTOR pathway-induced autophagy.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 16, 2024

Isoliquiritin targeting m5C RNA methylation improves mitophagy in doxorubicin-induced myocardial cardiotoxicity.

Isoliquiritin targeting m5C RNA methylation improves mitophagy in doxorubicin-induced myocardial cardiotoxicity.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 20, 2024

Changes in the immune microenvironment during plasma cell tumor development in the IL6Myc mouse model of human multiple myeloma.

Changes in the immune microenvironment during plasma cell tumor development in the IL6Myc mouse model of human multiple myeloma.

Journal: Experimental cell research

Published: July 30, 2024

Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma.

Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma.

Journal: Journal of translational medicine

Published: June 27, 2024

m1A regulator‑mediated methylation modifications and gene signatures and their prognostic value in multiple myeloma.

m1A regulator‑mediated methylation modifications and gene signatures and their prognostic value in multiple myeloma.

Journal: Experimental and therapeutic medicine

Published: June 04, 2024

Paeoniflorin inhibits angiogenesis in multiple myeloma by decreasing the MEF2A level to downregulate the expression of lncRNA MALAT1 within exosomes.

Paeoniflorin inhibits angiogenesis in multiple myeloma by decreasing the MEF2A level to downregulate the expression of lncRNA MALAT1 within exosomes.

Journal: Scientific reports

Published: April 07, 2024

Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma.

Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma.

Journal: Communications biology

Published: February 06, 2024

Identification of an angiogenesis-related risk score model for survival prediction and immunosubtype screening in multiple myeloma.

Identification of an angiogenesis-related risk score model for survival prediction and immunosubtype screening in multiple myeloma.

Journal: Aging

Published: September 26, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026